Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Publication Type:

Journal Article

Source:

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Volume 20, Issue 4, p.638-46 (2011)

Keywords:

2011, 5-alpha Reductase Inhibitors, Aged, Carotenoids, Case-Control Studies, Finasteride, Humans, Male, Middle Aged, Prostatic Neoplasms, Public Health Sciences Division, Risk Factors, Tumor Markers, Biological

Abstract:

Lycopene has been promoted for prostate cancer prevention, despite the inconsistency of scientific evidence.